SequelSEC

SERA PROGNOSTICS, INC. SERA

Services-Medical Laboratories · CIK 0001534969 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$70.00K
Fiscal year ended 2026-06-30
Operating income
-$37.30M
Fiscal year ended 2026-06-30
Free cash flow
-$28.15M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$82.90MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float / revenue1023.5×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Medical Laboratories filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
CapEx / revenue896.3%100th
FCF margin-32529.6%0th
Gross margin-102.5%0th
SBC / revenue6308.6%100th
Net margin-39417.3%5th
Operating margin-45066.7%5th
R&D / revenue16260.5%94th
Revenue YoY growth5.2%25th
Current ratio1.69x36th

SERA PROGNOSTICS, INC. (SERA) reported revenue of $70.00K and net income of -$33.23M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from SERA PROGNOSTICS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.

Income

SERA PROGNOSTICS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$70.00K
Cost of revenue$175.00K
Gross profit-$105.00K
Operating income-$37.30M
Net income-$33.23M
Research & development$13.02M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$24.17M
General & administrative$16.66M
Selling & marketing$7.51M

Balance

SERA PROGNOSTICS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$4.40M
Total assets$86.74M
Current assets$48.13M
Total liabilities$27.36M
Current liabilities$24.36M
Total equity incl. NCI$59.38M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$10.00K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$1.19M

Cash flow

SERA PROGNOSTICS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$27.68M
Capital expenditures$466.00K
Investing cash flow$26.44M
Financing cash flow$626.00K
Net change in cashUnavailable
Stock-based compensation$3.93M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$813.00K

Derived

SERA PROGNOSTICS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$28.15M
Gross margin-150.0%
Operating margin-53282.9%
FCF margin-40211.4%
SBC / revenue5615.7%
Current ratio1.98x
Revenue YoY growth-35.2%
Net margin-47475.7%
R&D / revenue18604.3%
CapEx / revenue665.7%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SERA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-03-18View SEC filing
10-Q · Filed 2025-11-13View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

ACON ADVB AMS BDSX BGLC BLLN CAI CDNA CELC CFOR CSTL DGX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.